<DOC>
	<DOCNO>NCT02917681</DOCNO>
	<brief_summary>The study aim evaluate primarily safety two injection autologous mesenchymal stem cell Amyotrophic Lateral Sclerosis patient . Secondary outcome efficacy also evaluate</brief_summary>
	<brief_title>Study Two Intrathecal Doses Autologous Mesenchymal Stem Cells Amyotrophic Lateral Sclerosis</brief_title>
	<detailed_description>The study open-label , unmasked , uncontrolled phase I II trial evaluate safety efficacy two injection autologous mesenchymal stem cell ( MSC ) Amyotrophic Lateral Sclerosis ( ALS ) patient . Patients recruit trough web-based registration system , open ALS Brazilian patient . The patient enrol in-person screening University Sao Paulo Medical School Clinics Hospital inclusion criterion fulfil . There 9 national call registration , two month apart . The enrolled patient follow 3 month bone marrow aspiration ( BMA ) . Patients receive 2 intrathecal MSC injection , 1 2 month BMA . The patient follow 6 month intervention .</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Motor Neuron Disease</mesh_term>
	<mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
	<criteria>1 . Age 18 70 2 . Possible , probable definite ALS follow El Escorial Revised Criteria ( Brooks , 2000 ) 3 . ALSFRSr ≥30 enrollment 4 . Forced Vital Capacity ≥65 % height weight standard 5 . Nopregnancy agreement 6 . Regional accessibility study site 7 . Capability give away agree consensus 8 . Patients follow Academic Institutions hometown 1 . Previous cellular therapy 2 . Incapacity lay still bone marrow aspirate intrathecal MSC injection 3 . Personal history autoImmune , myeloproliferative myelodysplastic disease , leukemia , lymphoma , wholebody irradiation , hip fracture , severe scoliosis incapacity undergo study 's proposed procedure 4 . Any disease may interfere study 5 . Any neurological disease 6 . Aspartate alanine aminotransferase elevate &gt; 3x normality upper limit 7 . Serum creatinine &gt; 2x normality upper limit 8 . Hepatitis B C , HIV , HTLV I II syphilis 9 . Immunosuppressant drug use within 6 week study 's screen 10 . Pregnancy breastfeed 11 . Acquired inherited Immunodeficiency 12 . Participation clinical trial 13 . Noninvasive ventilation , tracheostomy diaphragm pace 14 . Substance abuse within one year unstable mental health disease accord researcher 's judgement 15 . Gastrostomy alternative feeding mean 16 . Inappropriate invitro MSC expansion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>ALS</keyword>
	<keyword>mesenchymal stem cell</keyword>
	<keyword>intrathecal</keyword>
</DOC>